Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

High weight and obesity are associated with poor outcomes in leukemia treatment.

2.

Climate change is expected to increase the number of suicide deaths

3.

FDA Greenlights First Engineered Cell Therapy for a Solid Tumor

4.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

5.

Study reveals that older women frequently receive an incorrect breast cancer diagnosis.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot